Here are the 10-Q quarterly reports from Medicale Corp (MCLE) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MCLE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MCLE filings page.
Medicale Corp. reported another small quarterly loss and remains a development-stage company with no revenue and significant financial strain.
For the three months ended December 31, 2025, the company posted a net loss of $5,290, a sharp improvement from a $16,680 loss a year earlier, mainly because operating expenses dropped to $3,144 from $14,995. Interest expense from debt rose modestly to $2,146.
Despite the smaller loss, the balance sheet is very weak. Medicale had cash of $0, current liabilities of $32,202, and a working capital deficit of $32,202 as of December 31, 2025. Total liabilities were $145,376, including $113,174 of convertible notes, while stockholders’ deficit was also $145,376. The accumulated deficit reached $222,288 with 5,920,000 common shares outstanding.
Management states there is substantial doubt about the company’s ability to continue as a going concern and expects to rely on additional investment capital and further convertible note financing to fund basic operating costs while it attempts to launch its dietary supplements consulting and distribution business.